DE3680130D1 - Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung. - Google Patents

Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.

Info

Publication number
DE3680130D1
DE3680130D1 DE8686301196T DE3680130T DE3680130D1 DE 3680130 D1 DE3680130 D1 DE 3680130D1 DE 8686301196 T DE8686301196 T DE 8686301196T DE 3680130 T DE3680130 T DE 3680130T DE 3680130 D1 DE3680130 D1 DE 3680130D1
Authority
DE
Germany
Prior art keywords
globulin
gamma
heat treatment
virus inactivation
inactivation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686301196T
Other languages
English (en)
Inventor
Yutaka Hirao
Katuhiro Uriyu
Yahiro Uemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of DE3680130D1 publication Critical patent/DE3680130D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591Stabilisation, fragmentation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8686301196T 1985-02-21 1986-02-20 Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung. Expired - Lifetime DE3680130D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60033335A JPH0825902B2 (ja) 1985-02-21 1985-02-21 γ−グロブリンの加熱処理方法

Publications (1)

Publication Number Publication Date
DE3680130D1 true DE3680130D1 (de) 1991-08-14

Family

ID=12383686

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301196T Expired - Lifetime DE3680130D1 (de) 1985-02-21 1986-02-20 Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.

Country Status (7)

Country Link
EP (1) EP0196761B1 (de)
JP (1) JPH0825902B2 (de)
KR (1) KR940003941B1 (de)
CN (1) CN1006198B (de)
CA (1) CA1306691C (de)
DE (1) DE3680130D1 (de)
ES (1) ES8704733A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0825903B2 (ja) * 1985-05-16 1996-03-13 株式会社ミドリ十字 γ―グロブリン含有水溶液
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
US5248767A (en) * 1986-06-11 1993-09-28 Behringwerke Aktiengesellschaft Process for the preparation of a pasteurized immunoglobulin preparation using ethanol
CA1310267C (en) * 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
JP2618643B2 (ja) * 1987-08-18 1997-06-11 株式会社 ミドリ十字 静注用免疫グロブリン製剤
US4939176A (en) * 1988-12-20 1990-07-03 Miles Inc. Viral inactivation process
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンa製剤の製造法
JPH0565233A (ja) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc モノクローナル抗体含有凍結乾燥製剤
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4344824C1 (de) * 1993-12-28 1995-08-31 Immuno Ag Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
GB9418092D0 (en) * 1994-09-08 1994-10-26 Red Cross Found Cent Lab Blood Organic compounds
ES2091161B1 (es) * 1995-04-12 1997-05-16 Grifols Grupo Sa Procedimiento para la produccion de gammaglobulina intramuscular inactivada por pasteurizacion.
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
JP2775097B2 (ja) * 1996-08-29 1998-07-09 株式会社ミドリ十字 静注用免疫グロブリン製剤
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
US6124437A (en) * 1997-03-19 2000-09-26 Welfide Corporation Immunoglobulin preparation and preparation process thereof
CN1137727C (zh) * 1998-06-25 2004-02-11 四川远大蜀阳药业有限公司 无保护剂双重病毒灭活制备静注免疫球蛋白工艺
SI1475101T1 (sl) 2002-02-14 2011-03-31 Chugai Pharmaceutical Co Ltd Farmacevtski proizvodi iz raztopine, ki vsebuje protitelo
FR2853551B1 (fr) * 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
EP1532983A1 (de) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulinpräparationen mit erhöhter Stabilität
JP2010014685A (ja) * 2008-07-04 2010-01-21 Bio Matrix Research Inc タンパク質安定化溶液
AU2011212440B2 (en) 2010-02-04 2015-01-22 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (de) 2010-02-26 2011-08-31 CSL Behring AG Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat
FR2961107B1 (fr) * 2010-06-15 2012-07-27 Lab Francais Du Fractionnement Composition d'immunoglobulines humaines stabilisee
CN102167746B (zh) * 2010-11-11 2013-09-18 姜东成 Spg-抗体多聚体及其制备方法和应用
ES2381828B1 (es) 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5840532B2 (ja) * 1975-04-08 1983-09-06 カブシキガイシヤ ミドリジユウジ Iga オヨビ igm ノネツアンテイカホウ
JPS553721A (en) * 1978-06-21 1980-01-11 Morinaga Milk Ind Co Ltd Production of powder of colostrum
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第7因子含有水溶液の加熱処理方法
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives

Also Published As

Publication number Publication date
JPH0825902B2 (ja) 1996-03-13
KR860006478A (ko) 1986-09-11
ES8704733A1 (es) 1987-04-16
EP0196761B1 (de) 1991-07-10
EP0196761A2 (de) 1986-10-08
JPS61191622A (ja) 1986-08-26
CA1306691C (en) 1992-08-25
KR940003941B1 (ko) 1994-05-09
CN1006198B (zh) 1989-12-27
CN86101708A (zh) 1986-09-17
EP0196761A3 (en) 1986-10-22
ES552169A0 (es) 1987-04-16

Similar Documents

Publication Publication Date Title
DE3680130D1 (de) Verfahren zur vireninaktivierung in gamma-globulin durch waermebehandlung.
DE3577802D1 (de) Verfahren zur aktivierung von viren in immunoglobulin.
DE3583942D1 (de) Verfahren zur behandlung von fluiden.
DE3381940D1 (de) Verfahren zur metallbehandlung.
DE3485688D1 (de) Verfahren und vorrichtung zur behandlung von krankheiten.
DE3674308D1 (de) Biozide zusammensetzungund verfahren zur behandlung von wasser.
DE3382530D1 (de) Verfahren zur behandlung von ueberweisungen.
DE3685277D1 (de) Vorrichtung und verfahren zur herstellung von durchbrochenen vliesstoffen.
ATE49952T1 (de) Verfahren und vorrichtung zur herstellung von glasplatten.
DE3578698D1 (de) Verfahren zur behandlung von aluminiumoberflaechen.
DE3380895D1 (de) Verfahren zur behandlung von eiern.
DE3675632D1 (de) Verfahren zur einbringung von sauerstoff in wasser und vorrichtung zur durchfuehrung des verfahrens.
DE3877834D1 (de) Verfahren zur behandlung von abgasen.
DE3483344D1 (de) Verfahren zur reinigung von lpf-ha.
DE3687361D1 (de) Verfahren zur behandlung radioaktiver abfaelle.
DE3873094D1 (de) Verfahren zur aufbereitung von gas.
DE3668473D1 (de) Verfahren zur behandlung von oberflaechen und apparatur dafuer.
DE3668172D1 (de) Verfahren zur behandlung von aktiviertem siliciumpulver.
DE3781962D1 (de) Verfahren zur hitzebehandlung von chemisch unmodifiziertem gamma-globulin.
DE3670145D1 (de) Verfahren zur behandlung von abfall.
DE3674074D1 (de) Verfahren zur festigkeitsverbesserung durch waermebehandlung.
DE68903208D1 (de) Verfahren zur thermischen behandlung von laktoferrin.
DE3578161D1 (de) Verfahren zur behandlung von fluessigkeiten.
DE3671003D1 (de) Verfahren zur wasserbehandlung.
DE3877059D1 (de) Verfahren zur behandlung von abgasen durch strahlung und vorrichtung dafuer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD., OSAKA,

8327 Change in the person/name/address of the patent owner

Owner name: WELFIDE CORP., OSAKA, JP

8327 Change in the person/name/address of the patent owner

Owner name: MITSUBISHI PHARMA CORP., OSAKA, JP